1,2-Dibenzamidobenzene Inhibitors of Human Factor Xa-Reference-Cited by-同舟云学术

1,2-Dibenzamidobenzene Inhibitors of Human Factor Xa

Published:2000-02-23 Issue:5 Volume:43 Page:859-872
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Herron David K.¹,Goodson Theodore¹,Wiley Michael R.¹,Weir Leonard C.¹,Kyle Jeffrey A.¹,Yee Ying K.¹,Tebbe Ann Louise¹,Tinsley Jennifer M.¹,Mendel David¹,Masters John J.¹,Franciskovich Jeffry B.¹,Sawyer J. Scott¹,Beight Douglas W.¹,Ratz Andrew M.¹,Milot Guy¹,Hall Steven E.¹,Klimkowski Valentine J.¹,Wikel James H.¹,Eastwood Brian J.¹,Towner Richard D.¹,Gifford-Moore Donetta S.¹,Craft Trelia J.¹,Smith Gerald F.¹

Affiliation:

1. Lilly Research Laboratories, Eli Lilly & Company, Indianapolis, Indiana 46285, Sphinx Pharmaceuticals, Eli Lilly & Company, Durham, North Carolina 27707, and Sphinx Pharmaceuticals, Eli Lilly & Company, Cambridge, Massachusetts 02139

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm990326m

Reference35 articles.

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Progress of thrombus formation and research on the structure-activity relationship for antithrombotic drugs;European Journal of Medicinal Chemistry;2022-01

2. Contemporary medicinal-chemistry strategies for discovery of blood coagulation factor Xa inhibitors;Expert Opinion on Drug Discovery;2019-06-07

3. A Novel Fragment Recommendation Workflow using Direct and Indirect Transfer of SAR According to Integrated Similarities of Scaffold Motifs and SAR Trends: Application to Identifying Factor Xa Inhibitors;Chem-Bio Informatics Journal;2017

4. Discovery of N-[2-Hydroxy-6-(4-methoxybenzamido)phenyl]-4- (4-methyl-1,4-diazepan-1-yl)benzamide (Darexaban, YM150) as a Potent and Orally Available Factor Xa Inhibitor;Journal of Medicinal Chemistry;2011-11-11

5. Design, synthesis and SAR of novel ethylenediamine and phenylenediamine derivatives as factor Xa inhibitors;Bioorganic & Medicinal Chemistry Letters;2011-04